| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 16 | 15 | 12 | 17 | 13 | 14 | 16 | 16 | 7 | 16 | 17 | 19 | 16 | 19 | 20 | 18 | 18 | 19 | 19 | 20 | 23 | 21 | 24 | 22 | 26 | 26 | 26 | 31 | 33 |
| Expenses | 15 | 14 | 13 | 15 | 13 | 14 | 15 | 15 | 8 | 15 | 16 | 17 | 14 | 18 | 18 | 16 | 15 | 17 | 19 | 20 | 21 | 21 | 25 | 22 | 25 | 26 | 27 | 34 | 32 |
| EBITDA | 1 | 1 | -1 | 3 | 1 | -0 | 1 | 1 | -1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 3 | 2 | -0 | -0 | 2 | 0 | -0 | 1 | 1 | 0 | -1 | -3 | 1 |
| Operating Profit % | 4 % | 4 % | -7 % | 2 % | 3 % | -2 % | 7 % | 5 % | -12 % | 4 % | 7 % | 2 % | 8 % | 3 % | 8 % | 9 % | 15 % | 8 % | -0 % | -2 % | 6 % | -1 % | -3 % | 0 % | 4 % | -0 % | -4 % | -9 % | 2 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -0 | -0 | -2 | 1 | -1 | -1 | -0 | -0 | -2 | -0 | -0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 | -4 | -1 |
| Tax | -0 | 0 | 0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Net Profit | -0 | -0 | -2 | 2 | -1 | -1 | 0 | -0 | -2 | -0 | 0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 | -4 | -1 |
| EPS in ₹ | -1.16 | -0.56 | -4.46 | 2.96 | -1.55 | -2.59 | 0.01 | -0.66 | -3.68 | -0.50 | 0.16 | 2.23 | 0.27 | -0.67 | 1.63 | 1.29 | 3.84 | 1.68 | -2.05 | -3.80 | 1.04 | -2.32 | -2.48 | -1.81 | -0.50 | -2.41 | -4.03 | -7.03 | -2.02 |
GKB Ophthalmics
GKB Ophthalmics
72.41
-2.37
(-3.17%)
Market Cap
36.51 Cr
EPS
-13.98
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
122.95
52 Week Low
59.00
PB Ratio
0.72
Debt to Equity
0.23
Sector
Medical Equipment
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
KrishnaGopal Gupta & Sons (HUF) Purchases 334 Equity Shares in GKB Ophthalmics1 day ago
KrishnaGopal Gupta & Sons (HUF) purchased 334 equity shares of GKB Ophthalmics Limited on March 26, 2021, through market transactions. The purchase was disclosed under SEBI Insider Trading Regulations, with K.G. Gupta serving as Karta of the HUF. The transaction was reported to the Bombay Stock Exchange and the company's compliance officer. GKB Ophthalmics Limited has the ISIN code INE 265 D01015 and script code 533212.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,041.80 | #1 20,688.68 | 57.78 | #1 1,669.83 | 24.59 | #1 357 | 25.81 | 49.62 | |
331.95 | 1,824.47 | 78.98 | 236.56 | 19.23 | 29 | -50.60 | 26.87 | |
319.40 | 1,699.41 | 62.18 | 392.41 | -0.45 | 30 | -55.00 | 34.87 | |
613.40 | 1,019.58 | 62.56 | 249.37 | 40.00 | 17 | -20.59 | 48.35 | |
565.70 | 912.43 | 44.62 | 186.47 | 61.83 | 20 | - | 63.48 | |
583.90 | 700.90 | 36.35 | 67.10 | 30.58 | 18 | 18.92 | 55.41 | |
231.10 | 440.01 | #1 26.02 | 136.30 | #1 107.77 | 16 | - | 80.99 | |
308.00 | 321.56 | 39.22 | 111.60 | -1.43 | 8 | -0.10 | 89.84 | |
299.00 | 314.35 | 39.16 | 89.85 | 0.60 | 7 | #1 752.54 | 68.59 | |
257.10 | 257.10 | - | 122.10 | 19.24 | 1 | -52.94 | 64.97 |
Forecast
Actual
Growth Rate
Revenue Growth
22.83 %
Net Income Growth
136.67 %
Cash Flow Change
-181.28 %
ROE
170.26 %
ROCE
441.41 %
EBITDA Margin (Avg.)
-156.90 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 | 125 |
| Fixed Assets | 12 | 13 | 18 | 18 | 26 | 26 | 24 | 23 | 19 | 18 | 17 |
| Current Assets | 46 | 51 | 63 | 64 | 64 | 73 | 74 | 76 | 84 | 88 | 99 |
| Capital Work in Progress | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 3 | 4 | 4 | 4 |
| Investments | 0 | 6 | 4 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Other Assets | 63 | 50 | 60 | 64 | 67 | 75 | 80 | 82 | 87 | 91 | 102 |
| Total Liabilities | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 | 125 |
| Current Liabilities | 33 | 23 | 33 | 36 | 37 | 41 | 38 | 39 | 41 | 46 | 62 |
| Non Current Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 4 | 6 |
| Total Equity | 40 | 45 | 47 | 45 | 55 | 59 | 66 | 67 | 67 | 64 | 56 |
| Reserve & Surplus | 36 | 41 | 43 | 41 | 47 | 54 | 58 | 58 | 58 | 55 | 47 |
| Share Capital | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | 0 | -1 | 0 | 7 | 4 | -7 | -0 | -4 | 1 | -0 |
| Investing Activities | -1 | 15 | 4 | 1 | -10 | -4 | -17 | -4 | 1 | -2 | 3 |
| Operating Activities | 7 | -11 | -3 | -3 | 4 | 3 | 7 | 5 | -3 | 4 | -3 |
| Financing Activities | -6 | -3 | -1 | 1 | 13 | 4 | 3 | -2 | -2 | -2 | 1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 59.44 % | 59.24 % | 59.58 % | 59.69 % | 59.72 % | 59.73 % | 59.16 % | 59.09 % | 59.09 % | 59.18 % | 50.86 % | 50.88 % | 50.93 % | 50.95 % | 50.95 % | 50.98 % | 50.99 % | 51.06 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % |
| DIIs | 0.39 % | 0.39 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.93 % | 24.44 % | 24.90 % | 24.48 % | 24.63 % | 24.79 % | 24.82 % | 24.79 % | 27.11 % | 27.40 % | 36.01 % | 36.04 % | 36.04 % | 36.64 % | 36.34 % | 36.96 % | 37.36 % | 37.22 % |
| Others | 16.24 % | 15.93 % | 15.52 % | 15.83 % | 15.65 % | 15.47 % | 16.01 % | 16.11 % | 13.79 % | 13.41 % | 11.34 % | 11.28 % | 11.23 % | 10.63 % | 10.93 % | 10.27 % | 9.87 % | 9.94 % |
| No of Share Holders | 1,185 | 1,545 | 1,430 | 1,434 | 1,432 | 1,443 | 1,443 | 1,637 | 1,933 | 2,030 | 2,115 | 2,233 | 2,370 | 2,690 | 2,510 | 2,539 | 2,538 | 2,550 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Aug 2024 |  Annual General Meeting | NA | 20 Aug 2024 | 87.04 | 108.60 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 100.80 | 99.65 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 90.18 | 89.12 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 69.80 | 73.00 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 76.35 | 74.99 |
| 21 Aug 2025 | Annual General Meeting | NA | 21 Aug 2025 | 73.00 | 79.91 |
Announcements
Scrutinizers Report - Voting Results Of Annual General Meeting Held On August 21 2025.
Aug 22, 2025
Aug 22, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Aug 19, 2025Corrigendum To The Annual Report For The Financial Year 2024-2025.Aug 16, 2025
Aug 16, 2025GKB Ophthalmics Limited - Unaudited Standalone & Consolidated Financial Results - June 30 2025Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On August 14 2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Jul 30, 2025Reg. 34 (1) Annual Report.Jul 29, 2025
Jul 29, 2025Notice For Book ClosureJul 28, 2025
Jul 28, 2025GKB Ophthalmics Limited- Submission Of Annual Report For The Financial Year 2024-25Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Board Meeting Outcome for Disclosure Under Regulation 30 SEBI (LODR) Regulations 2015 - Outcome Of Board Meeting Of The Company Held On July 09 2025Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2025
Jun 02, 2025GKB- Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On May 30 2025May 30, 2025
May 30, 2025Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025May 14, 2025
May 14, 2025Intimation Of Change In Contact Details Of Registrar And Share Transfer Agent ("RTA") Of The CompanyApr 21, 2025
Apr 21, 2025Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018.Apr 10, 2025
Apr 10, 2025Announcement under Regulation 30 (LODR)-Credit RatingApr 09, 2025
Apr 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On March 31 2025.Apr 02, 2025
Apr 02, 2025Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure Requirements) Regulation 2015- Completion Of Tenure Of Independent Director And Re- Constitution Of Committees Of The Board.Mar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Outcome Of Independent Directors Meeting Held On March 27 2025.Mar 27, 2025
Mar 27, 2025Notice Of The Independent Directors MeetingMar 18, 2025
Mar 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Feb 19, 2025Integrated Filing (Financial)Feb 13, 2025
Feb 13, 2025GKB- Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 13, 2025
Feb 13, 2025Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Limited Held On February 13 2025Feb 13, 2025
Feb 13, 2025GKB Ophthalmics Limited Integrated Filling(Governance) For The Quarter Ended December 31 2024Feb 06, 2025
Feb 06, 2025Board Meeting Intimation for Consider And Take On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.Jan 24, 2025
Jan 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Jan 09, 2025Change In Name Of Registrar And Share Transfer Agent("RTA")Jan 09, 2025
Jan 09, 2025Outcome Of The Board Meeting Held On January 03 2025 And Execution Of Loan AgreementJan 03, 2025
Jan 03, 2025Sanctioning Of Loan Amount Of Rs. 5.00 Crores By Subsidiary Company To GKB Ophthalmics Limited Holding Company.Jan 02, 2025
Jan 02, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Dec 31, 2024
Dec 31, 2024Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Dec 31, 2024
Dec 31, 2024Closure of Trading WindowDec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015Dec 04, 2024
Dec 04, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 18, 2024
Nov 18, 2024Submission Of Consolidated Related Party Transaction As On September 30, 2024Nov 14, 2024
Nov 14, 2024Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.Nov 14, 2024
Nov 14, 2024Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2024 To Take On Record The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.Nov 14, 2024
Nov 14, 2024Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 30, 2024
Oct 30, 2024Technical Indicators
RSI(14)
Neutral 40.84
ATR(14)
Volatile 5.74
STOCH(9,6)
Oversold 13.58
STOCH RSI(14)
Oversold 1.30
MACD(12,26)
Bearish -0.81
ADX(14)
Weak Trend 20.37
UO(9)
Bearish 31.76
ROC(12)
Downtrend And Accelerating -12.45
WillR(14)
Oversold -97.74
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
